Atrium Therapeutics Inc (RNA)

Cash & Short-Term Investments

$264.21M

Quarterly · Period ending: · USD

RNA logo

RNA Cash & Short-Term Investments

Latest reported$264.21M
RNA Quarterly Cash & Short-Term Investments ($270.00M → $264.21M)
High-resolution chart · PNG

RNA cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
264,211,000
267,849,000
270,000,000
270,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.